Genmont Biotech Incorporation

Genmont Biotech Inc.

Wan-Hua Tsai

Yi-Hsing Chen

Chia-Hsuan Chou

Wen-Ling Yeh

Chih-Ho Lai

I-ling Hsu

Tsuei Yin Huang

Ming-Shiou Jan

Tsuei-Yin Huang

Pei-Jane Tsai

Wen-Wei Chang

Ying-Ju Chiang

Li-Jin Hsu

Yu-Hsin Lin

Ya-Hui Chen

Chia-Lin Wu

Ying-Chun Lai

Hsiang-En Huang

Yen-Wan Hsiao

Shiang-Suo Huang

Yi-Hsin Wang

Chi Chien Lin

Ching-gong Lin

Yu-Jen Hsu

Wee-wei Chieng

Shan-ju Hsu

Yao-Tsung Yeh

Junko Sugawara

Cheng-Hsieh Huang

Yu-Chieh Hung

Peng-Ju Chien

A method for preventing or treating oral cancer includes administering a composition comprisingor a supernatant of the heat-killed. A composition that contains an active ingredient with anti-oral cancer effect. The active ingredient isGMNL-346 or the supernatant of the heat-killed GMNL-346. The deposition number of theGMNL-346 is BCRC 910953 or CCTCC M 2019983.

Use ofGMNL-346 for anti-oral cancer treatment and thereof

Present invention discloses acomposition comprisingGMNL-263 which is a strain of heat-killed dead bacteria and has the effect of lowering blood pressure by inhibition of proinflammatory cytokine IL-1β and enhancement the growth of, and saidcomposition is a pharmaceutical composition, nutritional supplement, health food or a combination thereof.

GMNL-263 for improving hypertension and its compositions thereof

A method for promoting hair growth is disclosed. The method comprises a step of administeringGMNL-653 to a subject who needs to increase hair volume at a dose of 1.25×10to 5×10cells/ml/day, and theGMNL-653 was deposited at the China Center for Type Culture Collection located at Wuhan University, Wuhan 430072 P.R. China on Apr. 25, 2016 under an accession number CCTCC NO. M 2016226.

Method for promoting hair growth

The present invention provides acomposition and a use thereof for improving anxiety caused by antibiotics, wherein thecomposition comprisesGMNL-141,GM-020,GMNL-185, or a combination thereof. Thecomposition can effectively improve imbalance of an individual's intestinal flora caused by antibiotics to help stabilize and increase species richness and increase the synthesis of mood-stabilizing compounds, including flavonoids, flavonols, isoquinoline alkaloids, niacinamide, nicotinamide, and short-chain fatty acids in intestine, and thus effectively improve antibiotic-induced with anxiety disorders.

composition and use thereof for improving anxiety caused by antibiotics

A probiotic composition for improving an effect of a chemotherapeutic drug of Gemcitabine on inhibiting pancreatic cancer is disclosed in the present disclosure. The probiotic composition comprises an effective amount ofGMNL-133, an effective amount ofGMNL-89, and a pharmaceutically acceptable carrier, wherein theGMNL-133 was deposited in the China Center for Type Culture Collection on Sep. 26, 2011 under an accession number CCTCC NO. M 2011331, and theGMNL-89 was deposited in the China Center for Type Culture Collection on Nov. 19, 2007 under an accession number CCTCC NO. M 207154. A method for improving the effect of the chemotherapeutic drug of Gemcitabine on inhibiting pancreatic cancer is further disclosed in the present disclosure.

Method for improving an effect of chemotherapeutic drug of gemcitabine on inhibiting pancreatic cancer and improving side effect of chemotherapeutic drug of Gemcitabine

The present invention relates to a plant growth regulator of elevating anti-stress ability and use thereof. The plant growth regulator, which is consisted offermenting culture solution, has excellent thermostability and safety without any side effect, significantly elevating ability against biotic and abiotic stresses. Therefore, thefermenting culture solution can be applied as the plant growth regulator or a use in preparation of a composition for elevating anti-stress ability of a plant.

Plant growth regulator of elevating anti-stress ability and use thereof

A probiotic composition of improving memory and learning ability is disclosed. The probiotic composition comprisesGMNL-185 andGMNL-680, wherein theGMNL-185 was deposited in the China Center for Type Culture Collection in Wuhan, China on Nov. 3, 2017 under an accession number CCTCC NO. M 2017764, and theGMNL-680 was deposited in the China Center for Type Culture Collection in Wuhan, China on Nov. 3, 2017 under an accession number CCTCC NO. M 2017766, wherein a ratio of a number of bacteria of theGMNL-185 to a number of bacteria of theGMNL-680 is 1:1.

Method of improving memory and learning ability

A composition havingstrain GMNL-662 for promoting bone regrowth is provided. Thestrain GMNL-662 has an ability to promote the expression of osteogenic genes, inhibit the expression of osteoclast related genes, and promote the expression of osteogenesis-related cytokine TGF-&#x3b2;, so that the bone loss is improved.

Method of promoting bone regrowth

The present invention relates to a topical composition of facilitating wound healing and reducing scars, which includes an inactivated culture ofspecies as an effective ingredient and can significantly facilitate wound healing as well as reducing scars, thereby can be applied to a method of facilitating wound healing and reducing scars.

Topical composition, pharmaceutical composition containing inactivated culture and method of facilitating wound healing and scar reduction using the same

The present invention provides a use for probiotic preparing skin care composition, wherein the probiotic comprises(GMNL-6) with preservation number of BCRC 910777 or CCTCC M 2017765. The composition may be externally-coating drug, pharmaceuticals for external use, care products for external use or cosmetics, and may achieve the effects of improving the skin conditions or aesthetic appearance by promoting secretion of collagen or expression of ceramide synthase.

Use of lactobacillus plantarum GMNL-6 composition for skin care

The present invention provides a pharmaceutical composition and a food product for inhibiting gastritis induced by gastric, comprisingselected from a group composed ofGM-020 (also known as GMNL-74) with deposited number CCTCC M203098;GMNL-185 with deposited number CCTCC M2017764; andGMNL-662 with deposited number CCTCC M2016571; and any two of the above bacteria.

Lactobacillus composition for inhibiting gastritis induced by gastric helicobacter pylori and use thereof

The present invention provides a composition for preventing stroke and ameliorating the severity of stroke and comprises an effective dose ofGMNL-89 andGMNL-133; the accession number ofGMNL-89 is CCTCC M207154 and the accession number ofGMNL-133 is CCTCC M2011331. The composition can be taken as a dietary supplement and be given continuously after a stroke, and said composition has the effects of ameliorating cerebral infarction, motor function, and intestinal microbiota after a stroke.

Use of a probiotic composition for preventing stroke and ameliorating the severity of stroke

The present invention relates to a probiotic composition for preventing, improving or alleviating pancreatic cancer and a method for preventing, improving or alleviating the pancreatic cancer and its complications using the probiotic composition. The probiotic composition, which is consisted of specific strains and specific ratio ofto, can significantly improve or alleviate various symptomatic indicators and severity of pancreatic cancer, thereby being applied on a method for preventing, improving or alleviating the pancreatic cancer and its complications using an oral composition including thestrains.

Probiotic composition for preventing, improving or alleviating pancreatic cancer and application thereof

Use offor preparing for a combination for alleviating axillary osmidrosis is provided in the present invention, whereinrefers in particular toGMNL-653, featuring abilities of aggregating and inhibiting pathogens of axillary osmidrosis for alleviation of armpit odors and presented as a topical medication or a combination of cosmetics in which fragrance is added.

Use ofGMNL-653 for preparing for a composition for alleviating axillary osmidrosis

A composition is used for prevention or treatment of bacterial vaginosis (BV) and regulation of vaginal immunity and said composition with effective amount is selected from the groups comprisingGMNL-680 andGMNL-682; the composition of the present invention is used to prevent and treat bacterial vaginosis by inhibition of the growth of pathogens and regulation of the expression of immunoregulators and is prepared in the forms of pharmaceutical compositions, food or other combinations thereof.

Growing community of inventors

Kaohsiung, Taiwan

Wan-Hua Tsai